跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
DIACETYLMORPHINE HYDROCHLORIDE
Authorized
STANDARD
DIACETYLMORPHINE HYDROCHLORIDE
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
198bc6a50022c512
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
198bc6a50022c512
Drug Approval Canada Name
DIACETYLMORPHINE HYDROCHLORIDE
Product Name
DIACETYLMORPHINE HYDROCHLORIDE
Status
Marketed
Status Date
2022-04-11
Original Market Date
2022-04-11
Din
02525003
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N07BC06 DIAMORPHINE
Atc Name
n 07 bc 06
Aig Number
0117249004
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
DIAMORPHINE HYDROCHLORIDE
5000 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
198bc6a50022c512
Type
Standard
Back to Health Canada Approvals
DIACETYLMORPHINE HYDROCHLORIDE - Health Canada Drug Approval Details